Skip to content

Test the Outdoor Usage for Sunscreen Products in Female Adults

Supervised Outdoor -Use Test for Sunscreen Products in Female Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02779270
Enrollment
105
Registered
2016-05-20
Start date
2015-09-26
Completion date
2015-09-27
Last updated
2018-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sunscreening Agents

Brief summary

To assess the safety of a sunscreen product when used outdoor.

Interventions

DRUGBAY987518

Apply the assigned test product to all sun-exposed areas of the face and body while avoiding contact with mouth, eyes and eyelids. Formulation: V27-104

DRUGSunscreen Lotion (U77-030 Control)

Apply the assigned test product to all sun-exposed areas of the face and body while avoiding contact with mouth, eyes and eyelids.

Sponsors

Bayer
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Subjects must be healthy, fair skinned females between the ages of 18 to 65 years with no medical conditions of the skin. * Subjects must have Fitzpatrick Skin Types I, II, III, or IV. * Subjects must agree to restrict their sun exposure activities for at least five days. * Subjects must be willing and physically able to spend approximately 3 continous hours in the sun.

Exclusion criteria

* Subjects must not have actinic keratoses, skin cancer, psoriasis, eczema, or any other acute or chronic skin conditions as determined by the dermatological medical history. * Subjects must not have visible erythema, blistering, or peeling that would indicate recent sunburn. * Subjects must not have significantly tanned skin. * Subjects must not have received any phototoxic agent or any medication to which they have a known sensitivity or allergy.

Design outcomes

Primary

MeasureTime frame
Skin response to sun exposure according to the Skin Evaluation Response Scale from 0 to 3After approximately three hours direct sun-exposure

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026